ArticleFrontiers in bioinformatics2025
Computational analysis of transcriptome data and mapping of functional networks in Parkinson's disease.
Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is the most common neurodegenerative movement disorder. The pathophysiology is defined by a loss of dopaminergic neurons in the substantia nigra pars compacta, however recent studies suggest that the peripheral immune system may participate in PD development. Herein, we analyzed molecular insights examining RNA-seq data obtained from the peripheral blood of both Parkinson's disease patients and healthy control. Although all age and gender groups were analyzed, emphasis is given on individuals aged 50-70, the most prevalent group for Parkinson's diagnosis. The computational workflow comprises both bioinformatics analyses and machine learning processes and the yield of the pipeline includes transcripts ranked by their level of significance, which could serve as reliable genetic signatures. Classification outcomes are also examined with a focus on the significance of selected features, ultimately facilitating the development of gene networks implicated in the disease. The thorough functional analysis of the most prominent genes, regarding their biological relevance to PD, indicates that the proposed framework has strong potential for identifying blood-based biomarkers of the disease. Moreover, this approach facilitates the application of machine learning techniques to RNA-seq data from complex disorders, enabling deeper insights into critical biological processes at the molecular level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.